L'Anrs à la 7e Conférence de l'IAS
L'Anrs sera présente à la 7e Conférence de l'IAS qui se déroulera du 30 juin au 3 juillet 2013 à Kuala Lumpur, Malaisie
Un symposium satellite Anrs
What can we learn from Post-treatment Controllers? (mardi 2 juillet de 18h30 à 20h30 - Mini room 3)
Long-term control of HIV replication has been observed in patients from France who initiated cART during primary infection, then stopped the treatment. The ANRS VISCONTI study of 14 post-treatment controllers (PTC) shows that these patients present low levels of HIV reservoirs, like natural HIV controllers (HIC), but have different immune-genetic characteristics. Moreover, the probability of viral control after interruption of a durable treatment initiated early in primary infection appears higher (5-15%) than the frequency of spontaneous control (<1%). Once off treatment, PTC presented a skewed distribution of the reservoir, which was further reduced over time. In recent reports, early treatment initiation also appears a key factor to achieve this status. The goal of this meeting is to discuss the frequency and the mechanisms underlying post treatment control in both acutely and chronically treated PTC. The ultimate goal is to promote international collaborative research.
Un symposium co-organisé par l'Anrs et Sidaction
Assessment of Health-related Quality of Life (HRQoL) in HIV/AIDS: why and how? (lundi 1er juillet de 18h30 à 20h30 - mini room 4)
In the context of equivalent efficacy of therapeutic strategies and of chronic evolution of HIV infection, HRQoL becomes an important endpoint. Despite increase of the patient perception assessment in studies, its measurement in HIV often lacks rigor, and investigators may lack experience in interpreting and publishing HRQoL data. This session will introduce methods for measuring HRQoL, heath status and Patient-Reported Outcomes (PRO) by presenting methodological and practical aspects in clinical studies, cohorts and community research programs e.g critical review of instruments in HIV/AIDS ; properties of HRQoL instruments in terms of reliability, validity and responsiveness; formulation of an HRQoL hypothesis; adaptation and linguistic validation; analysis/interpretation of scores; role of PRO and their relation to other clinical and biological endpoints.
Une pré-conférence soutenue par l'Anrs
Towards an HIV Cure (sur invitation uniquement) - samedi 29 et dimanche 30 juin - Ritz-Carlton Hotel
The Towards an HIV Cure Symposium is co-chaired by Françoise Barré-Sinoussi, IAS President, Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF), and Sharon Lewin, Director of the Infectious Diseases Unit, Alfred Hospital, Monash University. Under the auspices of the International AIDS Society, an international working group of researchers developed a Global Scientific Strategy: Towards an HIV Cure, which was launched at a scientific symposium in Washington, DC in July 2012. The objectives of the symposium are to develop knowledge on the priorities that future research must address in order to tackle HIV persistence; accelerate research on viral reservoirs as the way towards achieving a cure; provide an opportunity for participants to share ideas, debate, and network among their peers; promote better investments in HIV/AIDS cure research.
A propos de l'IAS
> Consultez le site de la conférence (http://www.ias2013.org)